EUVIMEDEUVIMED entdecken
Crossref

Abdominal Ultrasonography After Transrectal Filling With Contrast Agent ( AU ‐ TFCA ) for the T Staging of Colon Cancer

Tie Zhou, Chenxi Cai, Zili Zhang, Cheng Sun, Yanmin Kan, Jianmin Ding, Xiang Jing iD

Journal of Clinical Ultrasound · 2026-11 · 54 (9) · 2089-2097

DOI: 10.1002/jcu.70308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Ultrasound, online erschienen am 21.06.2026. Verfasst von Tie Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Third Central Hospital of Tianjin, Tianjin, China. Hauptthemen laut MEDLINE: Contrast Media, Colonic Neoplasms. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Tianjin medical key discipline (specialty) construction project, Tianjin health science and technology project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the diagnostic value of abdominal ultrasonography after transrectal filling with contrast agent (AU‐TFCA) in the local T staging of colon cancer.

Methods

This retrospective study included patients diagnosed with colon cancer at Tianjin Third Central Hospital between April 2022 and July 2023.

Results

Eighty‐six patients (mean age 68.5 ± 9.5; 49 men) were included. The number of patients in stages T1–T4 based on pathological results was 3, 6, 64, and 13, respectively. Kappa agreement: AU‐TFCA versus pathology, T3‐4 = 0.585, T4 = 0.793; CECT versus pathology, T3‐4 = 0.481, T4 = 0.429. ROC using lesion maximum diameter yielded optimal cutoffs of 3.35 and 4.45. AUC = 0.777 and AUC = 0.807. For detecting T3‐4: sensitivity 0.779, specificity 0.778, accuracy 0.779. For T4: sensitivity 0.846, specificity 0.699, accuracy 0.721.

Conclusions

AU‐TFCA might have higher sensitivity and specificity in preoperative T staging of colon cancer. AU‐TFCA might be a valuable tool for colon cancer preoperative T staging, with a better correlation with pathology for T staging than CECT. Still, results require confirmation due to the small number of early‐stage cases and the possibility of selection bias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaColonic NeoplasmsHumansNeoplasm StagingMaleRetrospective StudiesUltrasonographySensitivity and SpecificityFemaleAgedMiddle AgedAbdomenColon

Stichwörter der Autor:innen

AU‐TFCAcolon cancerdevelopment aidenhanced CTultrasound

Substanzen

Contrast Media

Autor:innen und Institutionen

  • The Third Central Hospital of Tianjin, Tianjin, China.
  • Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, China.
  • Artificial Cell Engineering Technology Research Center, Tianjin, China.
  • Tianjin Institute of Hepatobiliary Disease, Tianjin, China.

ORCID-Profile: Xiang Jing

Förderung

  • Tianjin medical key discipline (specialty) construction project
  • Tianjin health science and technology project

Zitieren

APA

Zhou, T., Cai, C., Zhang, Z., Sun, C., Kan, Y., Ding, J., & Jing, X. (2026). Abdominal Ultrasonography After Transrectal Filling With Contrast Agent ( AU ‐ TFCA ) for the T Staging of Colon Cancer. Journal of Clinical Ultrasound, 54(9), 2089-2097. https://doi.org/10.1002/jcu.70308

Vancouver

Zhou T, Cai C, Zhang Z, Sun C, Kan Y, Ding J, et al. Abdominal Ultrasonography After Transrectal Filling With Contrast Agent ( AU ‐ TFCA ) for the T Staging of Colon Cancer. Journal of Clinical Ultrasound. 2026;54(9):2089-2097. doi:10.1002/jcu.70308

BibTeX
@article{Zhou2026,
  author = {Zhou, Tie and Cai, Chenxi and Zhang, Zili and Sun, Cheng and Kan, Yanmin and Ding, Jianmin and Jing, Xiang},
  title = {Abdominal Ultrasonography After Transrectal Filling With Contrast Agent ( AU ‐ TFCA ) for the T Staging of Colon Cancer},
  journal = {Journal of Clinical Ultrasound},
  year = {2026},
  volume = {54},
  number = {9},
  pages = {2089--2097},
  doi = {10.1002/jcu.70308}
}
Kostenlos starten →